1. Home
  2. SHEL vs MRK Comparison

SHEL vs MRK Comparison

Compare SHEL & MRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Shell PLC (each representing two (2))

SHEL

Shell PLC (each representing two (2))

HOLD

Current Price

$89.15

Market Cap

258.7B

Sector

Energy

ML Signal

HOLD

Logo Merck & Company Inc. (new)

MRK

Merck & Company Inc. (new)

HOLD

Current Price

$112.09

Market Cap

268.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SHEL
MRK
Founded
1907
2000
Country
United Kingdom
United States
Employees
85000
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
258.7B
268.7B
IPO Year
N/A
1994

Fundamental Metrics

Financial Performance
Metric
SHEL
MRK
Price
$89.15
$112.09
Analyst Decision
Buy
Buy
Analyst Count
10
17
Target Price
$93.79
$125.59
AVG Volume (30 Days)
7.3M
7.6M
Earning Date
05-07-2026
04-30-2026
Dividend Yield
3.25%
3.06%
EPS Growth
N/A
8.01
EPS
N/A
7.28
Revenue
N/A
$65,011,000,000.00
Revenue This Year
$21.75
$3.61
Revenue Next Year
N/A
$5.41
P/E Ratio
$26.62
$15.03
Revenue Growth
N/A
1.31
52 Week Low
$64.81
$75.40
52 Week High
$94.90
$125.14

Technical Indicators

Market Signals
Indicator
SHEL
MRK
Relative Strength Index (RSI) 49.10 43.28
Support Level $89.01 $105.23
Resistance Level $92.95 $112.44
Average True Range (ATR) 1.46 2.90
MACD -0.28 -0.69
Stochastic Oscillator 49.76 34.39

Price Performance

Historical Comparison
SHEL
MRK

About SHEL Shell PLC (each representing two (2))

Shell is an integrated oil and gas company that explores for, produces, and refines oil around the world. In 2024, it produced 1.5 million barrels of liquids and 7.7 billion cubic feet of natural gas per day. At year-end 2024, reserves stood at 9.6 billion barrels of oil equivalent, 48% of which consisted of liquids. Its production and reserves are in Europe, Asia, Oceania, Africa, and North and South America. The company operates refineries with a capacity of 1.6 mmb/d located in the Americas, Asia, and Europe, and sells about 12 million tons per year of chemicals. Its largest chemical plants, often integrated with its local refineries, are in Central Europe, China, Singapore, and North America.

About MRK Merck & Company Inc. (new)

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).

Share on Social Networks: